Skip to content

Analysis of salivary proteins in patients with Autism

Analysis of the salivary proteomic profile of patients with Autism Spectrum Disorder

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-9wghmd9
Enrollment
140
Registered
2026-07-28
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder Proteome

Interventions

This is a prospective observational cohort study whose overall objective is to identify the proteomic profile of saliva in patients diagnosed with Autism Spectrum Disorder, correlating it with the dif
to assess whether there are differences in the salivary proteomic profile according to each level of support
to assess whether there are differences in the proteomic profile between adults and children within each level of support
correlate changes in the salivary proteomic profile with oral changes observed in patients according to each level of support
and, using a validated tool, assess the perceived levels of stress and burden among the primary caregivers of the patients included in the sample. Saliva will be collected using an aspiration device,
10 patients aged 18 to 30 years. Total of 20 patients. Group 2 (support level 2): 10 patients aged 5 to 18 years
10 patients aged 18 to 30 years. Total of 20 patients. Group 3 (Level 3 support): 10 patients aged 5 to 18 years
10 patients aged 18 to 30 years. Total of 20 pat

Sponsors

Universidade de São Paulo
Lead Sponsor
Universidade de São Paulo
Collaborator

Eligibility

Age
5 Years to 30 Years

Inclusion criteria

Inclusion criteria: Individuals with a confirmed diagnosis of Autism Spectrum Disorder across the three different levels of support collaborative care, care provided at the Specialty Clinic for Patients with Special Needs at the Barradas Medical Specialty Clinic; aged 5 to 30 years

Exclusion criteria

Exclusion criteria: Patients with Autism Spectrum Disorder classified as non-cooperative; patients with systemic conditions of inflammatory and autoimmune origin; patients complaining of dry mouth

Design outcomes

Primary

MeasureTime frame
We expect to find differences in the salivary proteomic profile of patients with Autism Spectrum Disorder, as determined by salivary analysis, compared to those without a diagnosis of the disorder.;It is hoped that, by analyzing the salivary proteomic profile, potential salivary biomarkers will be identified that can aid in assessing compatibility with the level of support, treatment options, and, eventually, diagnostic and therapeutic strategies for this patient population.;Based on the protein changes identified across different patient profiles and levels of care, it is hoped that we will be able to determine whether there is an increased susceptibility to changes in oral health

Secondary

MeasureTime frame
It is expected that direct caregivers of patients with Autism Spectrum Disorder will experience high levels of burnout and job satisfaction.

Countries

BR

Contacts

Public ContactIsis Ghelardi

Universidade de São Paulo

isisraquel@usp.br+55 (11) 984567522

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026